Comparative study of mortality and morbidity in premature infants (birth weight, <1,250 g) with candidemia or candidal meningitis

Clinical Infectious Diseases

Volumn 27, Issue 3, 1998, Pages 559-565

  Lee, Bonita E ^b   Cheung, Po Yin ^b   Robinson, Joan L ^a   Evanochko, Christene ^b   Robertson, Charlene M T ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; DATA ANALYSIS; HUMAN; INFANT; MENINGITIS; MORBIDITY; MORTALITY; NERVE CELL DIFFERENTIATION; PREMATURITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 0031694679     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514712     Document Type: Article

References (25)

1. Baley JE, Kliegman RM, Fanaroff AA. Disseminated fungal infections in very low-birth-weight infants: clinical manifestations and epidemiology. Pediatrics 1984;73:144-52.
2. Stamos JK, Rowley AH. Candidemia in a pediatric population. Clin Infect Dis 1995;20:571-5.
3. Leibovitz E, Iuster-Reicher A, Amitai M, Mogilner B. Systemic Candidal infections associated with use of peripheral venous catheters in neonates: a 9-year experience. Clin Infect Dis 1992;14:485-91.
4. Baley JE. Neonatal candidiasis: the current challenge. Clin Perinatol 1991;18:263-80.
5. Baley JE, Kliegman RM, Fanaroff AA. Disseminated fungal infections in very low-birth-weight infants: therapeutic toxicity. Pediatrics 1984;73:153-7.
6. Faix RG. Systemic Candida infections in infants in intensive care nurseries: high incidence of central nervous system involvement. J Pediatr 1984;105:616-22.
7. Weese-Mayer DE, Fondriest DW, Brouillette RT, Shulman ST. Risk factors associated with candidemia in the neonatal intensive care unit: a case-control study. Pediatr Infect Dis J 1987;6:190-6.
8. Baley JE, Rivers A, Clapp DW, Hack M. Two year outcome of systemic candidiasis in VLBW infants [abstract]. Pediatr Res 1988;23:441 A.
9. Rodriguez AF, Kaplan SL, Mason EO Jr. Cerebrospinal fluid values in the very low birth weight infant. J Pediatr 1990;116:971-4.
10. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weight less than 1500 grams. J Pediatr 1978;92:529-34.
11. Robertson CMT, Hrynchyshyn GJ, Etches PC, Pain KS. Population-based study of the incidence, complexity, and severity of neurologic disability among survivors weighing 500 through 1250 grams at birth: a comparison of two birth cohorts. Pediatrics 1992;90:750-5.
12. Bayley N. Manual for the Bayley scales of infant development. New York: Psychological Corp., 1969.
13. Thorndyke RL, Hagen EP, Statler JM. The Stanford-Binet intelligence scale. 4th ed. Chicago: The Riverside Publishing Co., 1986.
14. Folio MR, Fewell RR. Peabody developmental motor scales. Allan, Texas: DLM Teaching Resources, 1983.
15. Robertson CMT, Etches PC, Kyle JM. Eight year performance and growth of preterm, small for gestational age infants: a comparative study with subjects matched for birth weight or for gestational age. J Pediatr 1990;116:19-26.
16. Bax MCO. Terminology and classification of cerebral palsy. Dev Med Child Neurol 1964;6:259-67.
17. Levine MS. Cerebral palsy diagnoses in children over age 1 year: standard criteria. Arch Phys Med Rehabil 1980;61:385-91.
18. Johnson DE, Thompson TR, Green TP, Fernen P. Systemic candidiasis in very low-birth-weight infants (<1,500 grams). Pediatrics 1984;73:138-43.
19. Butler KM, Rench MA, Baker CJ. Amphotericin as a single agent in the treatment of systemic candidiasis in neonates. Pediatr Infect Dis J 1990;9:51-6.
20. Phillips JR, Karlowicz MG. Prevalence of Candida species in hospital-acquired urinary tract infections in a neonatal intensive care unit. Pediatr Infect Dis J 1997;16:190-4.
21. Nagata MP, Gentry CA, Hampton EM. Is there a therapeutic or pharmacokinetic rationale for amphotericin B dosing in systemic Candida infections? Ann Pharmacother 1966;30:811-8.
22. Donowitz LG, Hendley JO. Short-course amphotericin B therapy for candidemia in pediatric patients. Pediatrics 1995;95:888-91.
23. Driessen M, Ellis JB, Cooper PA, et al. Fluconazole vs. amphotericin B for the treatment of neonatal fungal septicemia: a prospective randomized trial. Pediatr Infect Dis J 1996;15:1107-12.
24. Eppes SC, Troutman JL, Gutman LT. Outcome of treatment of candidemia in children whose central catheters were removed or retained. Pediatr Infect Dis J 1989;8:99-104.
25. Singer L, Yamashita T, Lilien L, Collin M, Baley J. A longitudinal study of developmental outcome of infants with bronchopulmonary dysplasia and very low birth weight. Pediatrics 1997;100:987-93.